Enhanced presentation of endogenous MHC class II-restricted peptides by tumor cell vaccines via RNAi-mediated down-regulation of Invariant chain

被引：0
|
作者：
Thompson, JA [1 ]
Dissanayake, SK [1 ]
Ostrand-Rosenberg, S [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21250 USA
来源：
FASEB JOURNAL | 2004年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A63 / A63
页数：1
相关论文
共 17 条
  • [1] PRESENTATION OF ENDOGENOUS ANTIGENS ON CLASS-II MHC - REGULATION BY THE INVARIANT CHAIN
    FRAUWIRTH, K
    SANDERSON, S
    SHASTRI, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 95 - 95
  • [2] Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
    Wenxue Ma
    Trevor Smith
    Vladimir Bogin
    Yu Zhang
    Cengiz Ozkan
    Mihri Ozkan
    Melanie Hayden
    Stephanie Schroter
    Ewa Carrier
    Davorka Messmer
    Vipin Kumar
    Boris Minev
    Journal of Translational Medicine, 9
  • [3] Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
    Ma, Wenxue
    Smith, Trevor
    Bogin, Vladimir
    Zhang, Yu
    Ozkan, Cengiz
    Ozkan, Mihri
    Hayden, Melanie
    Schroter, Stephanie
    Carrier, Ewa
    Messmer, Davorka
    Kumar, Vipin
    Minev, Boris
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [4] Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51
    Imai, Akihito
    Sahara, Hiroeki
    Tamura, Yasuaki
    Jimbow, Kowichi
    Saito, Tamotsu
    Ezoe, Kyori
    Yotsuyanagi, Takatoshi
    Sato, Noriyuki
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) : 1730 - 1738
  • [5] The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain
    Fineschi, B
    Sakaguchi, K
    Appella, E
    Miller, J
    JOURNAL OF IMMUNOLOGY, 1996, 157 (08): : 3211 - 3215
  • [6] MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity
    Irla, Magali
    Kuepfer, Natalia
    Suter, Tobias
    Lissilaa, Rami
    Benkhoucha, Mahdia
    Skupsky, Jonathan
    Lalive, Patrice H.
    Fontana, Adriano
    Reith, Walter
    Hugues, Stephanie
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (09): : 1891 - 1905
  • [7] MHC II-restricted peptides derived from invariant chain negative breast cancer cell-based vaccines activate healthy donor T-cells
    Chornoguz, Olesya
    Grmai, Lydia
    Gapeev, Alexei
    O'Neill, Michael
    Ostrand-Rosenberg, Suzanne
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [8] Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
    Bandola-Simon, Joanna
    Ito, Yoshinaga
    Wucherpfennig, Kai W.
    Roche, Paul A.
    CELL REPORTS, 2025, 44 (01):
  • [9] MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation
    Malcherek, G
    Wirblich, C
    Willcox, N
    Rammensee, HG
    Trowsdale, J
    Melms, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (05) : 1524 - 1533
  • [10] Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines
    Dolan, BP
    Phelan, TP
    Ilkovitch, D
    Qi, L
    Wade, WF
    Laufer, TM
    Ostrand-Rosenberg, S
    JOURNAL OF IMMUNOLOGY, 2004, 172 (02): : 907 - 914
12